Navigation Links
Innerscope Research(R) Uses Same-Day Results From Biometric Study to Identify Key Themes, Styles Behind Effective, Engaging Speaker Presentations
Date:3/20/2009

CEO Dr. Carl Marci to discuss results March 19 during 12 p.m. Advertising Research Foundation webcast

BOSTON, March 17 /PRNewswire/ -- Innerscope Research(R), a revolutionary media research firm, recently conducted a live biometric study of an Advertising Research Foundation (ARF) conference and provided attendees with same-day results that identified key themes and styles that comprise impactful presentations.

Results of the study, which were captured and delivered during the ARF's Industry Leader Forum on Jan. 27 in San Francisco, provided conference speakers with critical insights into how to prepare and organize presentations for maximum audience engagement. Among the findings: using video clips and calling the audience to action consistently register high engagement.

"The results were truly eye-opening and have permanently influenced how I communicate for lasting impact at conferences," said Joel Rubinson, Chief Research Officer at the Advertising Research Foundation.

Innerscope partnered with the ARF to examine how new technology can be used to "listen" to consumers and deliver deeper insights into the drivers of emotional engagement during presentations.

Innerscope CEO Dr. Carl Marci will share detailed findings on March 19 at 12 p.m. (EST) during a one-hour webcast titled, "You're Talking, But Who's Listening?" The webcast, which is free to ARF members, can be accessed at: www.thearf.org

"We were honored to be the first company to monitor the real-time emotional responses of ARF audience members during the presentations," said Dr. Carl Marci, CEO and cofounder of Innerscope Research. "The results again underscored the significance of understanding emotions in order to best connect with your audience."

Innerscope's study revealed the speed and flexibility of its breakthrough Biometric Monitoring System(TM). During the Industry Leader Forum, which included executives from Fortune 500 companies and top research firms, Innerscope biometrically monitored the moment-to-moment emotional engagement of more than 20 attendees as they listed to seven presentations. Among the participants were representatives from Kraft Foods Inc., Novartis Consumer Health Inc., Kimberly-Clark Corp., JD Power & Associates, TNS Company, OTX Research, and Young & Rubicam. Innerscope measured skin conductivity, heart response, respiratory response and motion in a wireless, garment-based system.

The four-hour session generated over five million data points. Innerscope analyzed the data and delivered initial insights to conference attendees during the event's closing remarks that afternoon. Additional details and insights will be revealed during the March 19 webcast.

About Innerscope Research(R)

Innerscope Research(R) is dedicated to solving difficult market research questions by measuring and analyzing subconscious emotional responses to media. With its breakthrough Biometric Monitoring System(TM), Innerscope accurately predicts consumer behaviors, providing Fortune 100 companies with an unprecedented level of consumer insight. Founded by Harvard and MIT scientists, Innerscope leverages the latest advances in biometrics, neuroscience and eye tracking to measure moment-to-moment emotional engagement, the primary driver of behavior and choice. For more information, visit http://www.innerscope.com


'/>"/>
SOURCE Innerscope Research
Copyright©2009 PR Newswire.
All rights reserved

Related biology news :

1. Innerscope Research(R) Appoints Digital Leader, Andre Marquis, as Senior Vice President of Sales and Marketing
2. Doubling a gene in corn results in giant biomass
3. Doubling a gene in corn results in giant biomass
4. Aware, Inc. Reports Fourth Quarter and 2008 Financial Results
5. Results of national nursery survey unveiled
6. Results of the third school nutrition dietary assessment study published
7. Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008
8. UH Manoa researchers release results of statewide survey of snail, slug invasions in Hawaii
9. bioMETRX, Inc. Highlights 3rd Quarter 2008 Financial Results
10. Orchid Cellmark Reports Third Quarter 2008 Financial Results
11. Positive results in Phase 2 trial of treatment of C-difficile-associated diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of 8.5 ... end machines that use the more unconventional z-dimension of 20mm. Z-dimension or ... the cuvette holder. , FireflySci has developed several Agilent flow cell product lines ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
Breaking Biology Technology: